Virtual Screening of Repurposed Drugs as Potential Spike Protein Inhibitors of Different SARS-CoV-2 Variants: Molecular Docking Study.

Eweas, Ahmad F; Osman, Hosam-Eldin H; Naguib, Ibrahim A; Abourehab, Mohammed A S; Abdel-Moneim, Ahmed S

Eweas, Ahmad F; Osman, Hosam-Eldin H; Naguib, Ibrahim A; Abourehab, Mohammed A S; Abdel-Moneim, Ahmed S.

Afiliação

Eweas AF; Department of Pharmaceutical and Medicinal Chemistry, National Research Centre, Cairo 12622, Egypt.
Osman HH; Department of Science, University of Technology and Applied Sciences Rustaq, Rustaq 133, Oman.
Naguib IA; Department of Anatomy, College of Medicine, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia.
Abourehab MAS; Department of Pharmaceutical Chemistry, College of Pharmacy, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia.
Abdel-Moneim AS; Department of Pharmaceutics, Faculty of Pharmacy, Umm Al-Qura University, Makkah 21955, Saudi Arabia.

Curr Issues Mol Biol ; 44(7): 3018-3029, 2022 Jul 04.

Article em En | MEDLINE | ID: mdl-35877432

Palavras-chave

COVID-19; SARS-CoV-2; VOC; VOI; alpha; beta; delta; omicron; variant

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Screening_studies Idioma: En Revista: Curr Issues Mol Biol Assunto da revista: BIOLOGIA MOLECULAR Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Egito

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google